Skip to main content
Clinical Trials/NCT03306992
NCT03306992
Completed
Phase 3

A Phase III Randomized Study Comparing the Effects of a Personalized Exercise Program (PEP) Against No Intervention in Patients With Stage I-IIIa Primary Non-Small Cell Lung Cancer or Secondary Lung Cancer Undergoing Surgical Resection

University of Utah1 site in 1 country200 target enrollmentNovember 7, 2017

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Non Small Cell Lung Cancer
Sponsor
University of Utah
Enrollment
200
Locations
1
Primary Endpoint
Evaluate the change in mobility performance at baseline, 2 months and 6 months
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is a Phase 3 study aimed at investigating the effects of a personalized exercise program (PEP) in NSCLC patients (stage I, II, IIIa) and secondary lung cancer patients undergoing surgical treatment at the University of Utah and comparing the intervention to the current standard of care (no exercise program).

Detailed Description

This is a Phase 3 study aimed at investigating the effects of a personalized exercise program (PEP) in NSCLC patients (stage I, II, IIIa) and secondary lung cancer patients undergoing surgical treatment at the University of Utah and comparing the intervention to the current standard of care (no exercise program). Eligible patients will be randomized between two arms (1:1 ratio) prior to the surgery and will be followed for approximately 6 months post-surgery: * An Intervention Arm (referred to in materials as Group 1) which features pre- and post-surgery PEP interventions. * A Control Arm (referred to in materials as Group 2) which does not include a personalized exercise program (the standard of care). Patients randomized to the Control Arm will be given the opportunity to participate in a PEP-intervention session providing exercise counseling after the 6 month assessment and will receive a free activity tracker for their participation.

Registry
clinicaltrials.gov
Start Date
November 7, 2017
End Date
May 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female subject aged ≥ 18 years.
  • Diagnosis of primary lung cancer stage I, II, or IIIa OR secondary lung cancer.
  • Disease amenable to surgical resection in the opinion of the treating surgeon.
  • Patients must be able to follow directions and complete questionnaires and exercise diaries in English.
  • Patients must agree to be randomly assigned to either Intervention or Control Group.

Exclusion Criteria

  • Deemed ineligible for surgery by the enrolling physician
  • Abnormalities on screening physical exam judged by study physicians or supervising physical therapist to contraindicate participation in exercise program compliance.
  • Alcohol or drug abuse as judged by study physicians.
  • Significant mental or emotional problems that would interfere with study participation will be assessed by the NCCN Distress Thermometer. Any value higher than 7 will trigger further intervention, but ultimately enrollment into the clinical trial will be determined by the enrolling physician.

Outcomes

Primary Outcomes

Evaluate the change in mobility performance at baseline, 2 months and 6 months

Time Frame: Done at baseline, 2 and 6 months

Six Minute Walk (6MW) distance. The distance patients can walk indoors on a 25 meters level smooth-surfaced track over the course of 6 minutes will be measured at baseline as well as at the time of discharge and at the 2 and 6 months follow-up.

Secondary Outcomes

  • Compare results from PROMIS Questionnaire done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months(Done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months)
  • Evaluate the change Short Physical Performance Battery (SPPB) score(Done at baseline, 2 and 6 months)
  • Compare results from FACT-L (Functional Assessment of Cancer Therapy-Lung) Questionnaire done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months(Done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months)
  • Compare results from FACIT-F (Chronic Illness Fatigue Scale) Questionnaire done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months(Done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months)
  • Compare results from PSQI (Pittsburgh Sleep Quality Index) Questionnaire done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months(Done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months)
  • Compare results from BREQ-3 (Behavioral Regulation in Exercise Questionnaire 3) Questionnaire done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months(Done at baseline, discharge (6-10 days after surgery on average), 2 and 6 months)

Study Sites (1)

Loading locations...

Similar Trials